Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Family History Biggest Predictor of Heart Attacks in People with Psoriasis

Lisa Rapaport  |  July 2, 2016

One limitation of the study is that researchers excluded more than 2.6 million people who had incomplete data on family history in Danish health registry records, which made the study population skew younger, the authors note. This makes it unclear if the findings would apply to people diagnosed with psoriasis later in life, the authors say.

Even so, the findings suggest that doctors should be asking psoriasis patients about their family histories, said Dr. Nehal Mehta, chief of the inflammation and cardiometabolic diseases section at the National Heart, Lung, and Blood Institute in Bethesda, Md.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The major take-home message from these findings should be for providers to inquire about a family history of major adverse cardiovascular events since it is also a cardinal risk factor for future major adverse cardiovascular events in non-psoriasis patients,” Mehta, who wasn’t involved in the study, says by email.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:cardiovascularheartPsoriasis

Related Articles

    Nature’s Inflammation Experiment

    August 1, 2008

    Familial Mediterranean fever a frequently misdiagnosed autoinflammatory disease

    MicroOne / shutterstock.com

    Rheumatology Drugs at a Glance, Part 2: Psoriasis

    May 17, 2019

    Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

    Many Medications: Understanding the Biologic Management of Psoriasis

    June 15, 2023

    ORLANDO, FLORIDA — Given the intersection between rheumatology and dermatology for many patients with autoimmune diseases, it’s helpful to hear from specialists in both fields regarding disease management strategies.

    A Heart In Danger

    November 1, 2006

    Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences